Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Agnus castus N Oligoplex is a registered homeopathic combination drug developed by Madaus (now a subsidiary of Viatris). It is formulated as an oral liquid (drops) containing a mixture of homeopathic active ingredients, including *Vitex agnus-castus* (chasteberry) D2, *Atropa belladonna* (deadly nightshade) D4, Nitroglycerinum (glyceryl trinitrate) D5, and Phosphorus D6. As a registered homeopathic medicine in Germany, it is marketed without specific therapeutic indications, though its components are traditionally associated with homeopathic support for various conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Agnus castus N Oligoplex.